Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997
Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter 39:53-54, , 1997
Prevalence and Severity of Cognitive Impairment with and without Dementia in an Elderly Population
Lancet 349:1793-1796, Graham,J.E.,et al, 1997
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
NEJM 336:1216-1222, 12451997., Sano,M.,et al, 1997
Antioxidants and Dementia
Lancet 349:1189-1190, Lethem,R.&Orrell,M., 1997
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
Reliability of Wash Univ Road Test:A Performance-Based Assess for Drivers with Dementia of Alzheimer Type
Arch Neurol 54:707-712, Hunt,L.A.,et al, 1997
Midline Cerebral Morphometry Distinguishes Frontotemporal Dementia and Alzheimer's Disease
Neurol 48:978-985, Kaufer,D.I.,et al, 1997
Simulated Car Crashes and Crash Predictors in Drivers with Alzheimer Disease
Arch Neurol 54:545-551, Rizzo,M.,et al, 1997
The Family Caregiver's Role in Alzheimer's Disease
Neurol 48 (Suppl 6) :S25-S29997., Haley,W.E., 1997
Cognitive Function and The costs of Alzheimer Disease
Arch Neurol 54:687-683, Ernst,R.L.,et al, 1997
Clinical Characteristics of a Chromosome 17-Linked Rapidly Progressive Familial Frontotemporal Dementia
Arch Neurol 54:539-544, Basun,H.,et al, 1997
Frontotemporal Dementia and Early Alzheimer Disease:Differentiation with Frontal Lobe H-1 MR Spectroscopy
Radiology 203:829-836, Ernst,T.,et al, 1997
Olfactory Dysfunction in Multiple Sclerosis
(Letter) NEJM 336:1918-1919997., Doty,R.L.,et al, 1997
Assessment of Olfaction in Multiple Sclerosis:Evidence of Dysfunction by Olfactory Evoked Response and Identification Tests
JNNP 63:145-151, Hawkes,C.H.,et al, 1997
Olfactory Dysfunction in Patients with Head Trauma
Arch Neurol 54:1131-1140, Doty,R.L.,et al, 1997
Clinical and Radiologic Findings in Progressive Facial Hemiatrophy (Parry-Romberg Syndrome)
AJNR 18:751-757, Cory,R.C.,et al, 1997
A 44-Month Clinical-Brain MRI Follow-Up in a Patient with B12 Deficiency
Neurol 49:878-881, Stojsavljevic,N.,et al, 1997
Cost Effectiveness of Oral Compared with IV Antibiotic Therapy for Pts with Early Lyme Dis or Lyme Arthritis
NEJM 337:357-363, Eckman,M.H.,et al, 1997
Neuro-Ophthalmic Manifestations of Lyme Disease
J Neuro-Ophthalmol 17:108-121, Balcer,L.J.,et al, 1997
Aluminum Neurotoxicity in Preterm Infants Receiving Intravenous-Feeding Solutions
NEJM 336:1557-1561, Bishop,N.J.,et al, 1997
Clinicopath Conf
Botulism, Case 22-1997, NEJM 337:184-190997., , 1997
Frequent & Frequently Overlooked:Trtm-Induced Endocrine Dysf in Adult Long-Term Survivors of Primary Brain Tumors
Neurol 49:498-506, Arlt,W.,et al, 1997
Clinicopath Conf
Hodgkin's Disease, Paraneoplastic Cerebellar Degeneration, Case 21-1997, NEJM 337:115-12297., , 1997
Bilateral Trochlear Nerve Palsy and Downbeat Nystagmus in a Patient with Cephalic Tetanus
Neurol 49:894-895, Orwitz,J.I.,et al, 1997
Serum Autoantibodies in Childhood Opsoclonus-Myoclonus Syndrome:Analysis of Antigenic Targets in Neural Tissues
J Pediatr 130:878-884, 8851997., Connolly,A.M.,et al, 1997
Olfactory Dysfunction in Parkinson's Disease
JNNP 62:436-446, Hawkes,C.H.,et al, 1997
Neurological Signs and Frontal White Matter Lesions in Vascular Parkinsonism
Stroke 28:965-969, Yamanouchi,H.&Nagura,H., 1997
Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997
Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997
Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997
Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997
Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997
Multifocal Motor Neuropathy Presenting as Ophthalmoplegia
Muscle & Nerve 20:347-351997., Pringle,C.E.,et al, 1997
Neurodevelopmental Dysfunction Among Nonreferred Children with Idiopathic Megalencephaly
J Pediatr 131:320-324, Sandler,A.D.,et al, 1997
An Early Marker for Neurological Deficits after Perinatal Brain Lesions
Lancet 349:1361-1363, Prechtl,H.F.R.,et al, 1997
Assessment of Digital EEG, Quantitative EEG, and EEG Brain Mapping
Neurol 49:277-292, Nuwer,M., 1997
Preliminary Results of Linear Accelerator Radiosurgery for Acoustic Schwannomas
J Neurosurg 85:1013-1019, Mendenhall,W.M.,et al, 1997
Silent Brain Infarction on Magnetic Resonance Imaging and Neurological Abnormalities in Community-Dwelling Older Adults
Stroke 28:1158-1164, Price,T.R.,et al, 1997
The X-Linked Infantile Spasms Syndrome (MIM 308350) Maps to Xp11. 4-Xpter in Two Pedigrees
Ann Neurol 42:360-364, Claes,S.,et al, 1997
Gabapentin and Cognition:A Double Blind, Dose Ranging, Placebo Controlled Study in Refractory Epilepsy
JNNP 62:372-376, Leach,J.P.,et al, 1997
Incontinence During Treatment with Gabapentin
Neurol 48:1467-1468, Gil-Nagel,A.,et al, 1997
New Variant Creutzfeldt-Jakob Disease:Neurological Features and Diagnostic Tests
Lancet 350:903-907, Zeidler,M.,et al, 1997
Pupil-Involving Third-Nerve Palsy and Carotid Stenosis:Rapid Recovery Following Endarterectomy
Ann Neurol 41:273-276, Balcer,L.J.,et al, 1997
Prevalence and Risk Factors of Incontinence After Stroke:The Copenhagan Stroke Study
Stroke 28:58-62, Nakayama,H.,et al, 1997
Association of Tuberous Sclerosis of Temporal Lobes with Autism and Atypical Autism
Lancet 349:392-395, Bolton,P.F.&Griffiths,P.D., 1997
Hereditary Frontotemporal Dementia is Linked to Chromosome 17q21-q22:Genetic & Clinicopath Study of 3 Dutch Families
Ann Neurol 41:150-159, Heutnik,P.,et al, 1997
Frontotemporal Dementia is on the MAP
Ann Neurol 41:139-140, Wilhelmsen,K.C., 1997
Alteration of White Matter MR Signal Intensity in Frontotemporal Dementia
AJNR 18:367-378, Kitagaki,H.,et al, 1997
Assessment of CSF Levels of Tau Protein in Mildly Demented Patients with Alzheimer's Disese
Neurol 48:632-635, Galasko,D.,et al, 1997